logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
24/07/2026
German Chancellor Merkel: There will be more changes in the future cabinet, which will require more time.
Latest
4 m ago
Romanian President: Romania shot down an unmanned drone that entered into our territory.
5 m ago
Goldman Sachs CEO David Solomon clearly stated his support for advancing the CLARITY Act during an interview, despite acknowledging that the bill is not perfect. "Like all legislation, the CLARITY Act has many areas that can be debated and disputed, but I believe one of the most important things it does is create a level playing field to enhance market stability and allow these markets to develop properly. I strongly support advancing the CLARITY Act so that we can establish some market structure and begin to drive the innovation process." Solomon's endorsement comes as Republican senators are discussing updates to the bill text, with a highly anticipated vote expected in the Senate next week, marking a further step towards the implementation of legislation for the encrypted market structure. Solomon's supportive stance contrasts sharply with the strong opposition from banking industry peers like JPMorgan CEO Jamie Dimon. Dimon stated in May that the latest version of the bill "allows them to actually pay interest on things like deposits, stablecoins, etc., without the proper protections" and warned that "banks will not accept this method in the end, it will explode". JPMorgan also suggested in a blog post in June that companies providing products with similar functionalities as traditional bank accounts should be subject to equivalent regulation and consumer protection. The controversy revolves around the yield terms of stablecoins.
5 m ago
Fulede (301297.SZ) expects to achieve a net profit attributable to the parent of 182 million to 222 million yuan in the first half of the year, a year-on-year increase of 58.62% to 93.51%.
5 m ago
Kangenbei's (600572.SH) subsidiary Muskol Drops has obtained approval for a new indication clinical trial application.
6 m ago
Northeast Securities: The largest shareholder has applied for restructuring, which may affect the company's equity structure.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.